Correlation Between Baillie Gifford and Dreyfusnewton International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Baillie Gifford and Dreyfusnewton International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Baillie Gifford and Dreyfusnewton International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Baillie Gifford Health and Dreyfusnewton International Equity, you can compare the effects of market volatilities on Baillie Gifford and Dreyfusnewton International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Baillie Gifford with a short position of Dreyfusnewton International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Baillie Gifford and Dreyfusnewton International.

Diversification Opportunities for Baillie Gifford and Dreyfusnewton International

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Baillie and Dreyfusnewton is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Baillie Gifford Health and Dreyfusnewton International Eq in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dreyfusnewton International and Baillie Gifford is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Baillie Gifford Health are associated (or correlated) with Dreyfusnewton International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dreyfusnewton International has no effect on the direction of Baillie Gifford i.e., Baillie Gifford and Dreyfusnewton International go up and down completely randomly.

Pair Corralation between Baillie Gifford and Dreyfusnewton International

Assuming the 90 days horizon Baillie Gifford Health is expected to generate 0.37 times more return on investment than Dreyfusnewton International. However, Baillie Gifford Health is 2.71 times less risky than Dreyfusnewton International. It trades about -0.04 of its potential returns per unit of risk. Dreyfusnewton International Equity is currently generating about -0.15 per unit of risk. If you would invest  603.00  in Baillie Gifford Health on September 21, 2024 and sell it today you would lose (30.00) from holding Baillie Gifford Health or give up 4.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Baillie Gifford Health  vs.  Dreyfusnewton International Eq

 Performance 
       Timeline  
Baillie Gifford Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Baillie Gifford Health has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, Baillie Gifford is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Dreyfusnewton International 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dreyfusnewton International Equity has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Baillie Gifford and Dreyfusnewton International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Baillie Gifford and Dreyfusnewton International

The main advantage of trading using opposite Baillie Gifford and Dreyfusnewton International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Baillie Gifford position performs unexpectedly, Dreyfusnewton International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dreyfusnewton International will offset losses from the drop in Dreyfusnewton International's long position.
The idea behind Baillie Gifford Health and Dreyfusnewton International Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets